// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Childhood respiratory risk factor profiles and lung function in middle age

Dinh Bui - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An airway challenge test can predict COPD: an international cohort study

Alessandro Marcon - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

SK1211

Effect of severity of exacerbations of COPD and hospitalised pneumonia on risk of myocardial infarction

Kieran Rothnie - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Myocardial infarction

N/A

Ten years evolution of cluster-based asthma phenotypes

Valerie Siroux - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Blood eosinophils and lung function decline in young adults

Robert Hancox - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Characteristics of adult onset vs. late onset asthma - a multinational database cohort study

Katia Mc Verhamme - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Late Breaking Abstract - Cluster analysis of treatable traits in the U-BIOPRED adult severe asthma cohort

Andrew Simpson - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Single inhaler triple therapy in patients with advanced COPD: healthcare resource utilisation and cost data from the FULFIL study

Afisi Ismaila - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland

Wai-Ting Nicola Lee - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Cost effectiveness of umeclidinium bromide 62.5μg plus ICS/LABA versus ICS/LABA in COPD

Maurice Driessen - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Umeclidinium

The cost burden of COPD in France: A retrospective analysis of an administrative primary care database

Wilhelmine Meeraus - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data

Afisi Ismaila - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Cost-effectiveness of umeclidinium bromide 62.5µg or alternative LAMA plus ICS/LABA in COPD

Maurice Driessen - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Umeclidinium

Cost-effectiveness of fixed-dose combinations therapies for COPD in Spain

Margarita Capel - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Tiotropium/olodaterol

Breathing exercises delivered by DVD or face to face physiotherapy-acceptability to patients in the BREATHE study

Anne Bruton - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Exploring professionals’ and managers’ perspectives of implementing asthma self-management: a qualitative study from the IMP2ART programme

Hilary Pinnock - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Educational interventions for professionals implementing supported self-management: a systematic review from the IMP2ART programme

Nicola McCleary - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

What features do patients ‘want’ in a mobile asthma app?: a qualitative study

Chi Yan Hui - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Evaluating the effectiveness of a locally developed Personal Asthma Action Plan (PAAP)

Jane Peach - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Effectiveness of community-based self-management interventions among primary care COPD patients: a systematic review

Kate Jolly - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Depression

N/A

Copyright © 2026. QuantiNova All rights reserved